31 Mar 2023
Assets1.74
Total Income3.49
EBITDA0.51
Profit After Tax0.41
NET Worth0.07
Reserves and Surplus0.07
Total Borrowing0.41
At a glance
Updated 2026-09-10The shares listed at ₹201.00, a 54.62% move from the issue price. Ravelcare is a SME IPO with an issue size of ₹24.10 crore, proposed for listing on BSE SME. The offer opens on 1st Dec 2025 and closes on 3rd Dec 2025. The issue structure includes a fresh issue of ₹22.88 crore. The current listing schedule points to 8th Dec 2025.
Issue details
Listing atBSE SME
Issue typeBook Build Issue
Issue size₹24.10 Cr
Fresh issue₹22.88 Cr
Face value₹10
Price band₹123.00–₹130.00
Allotment4th Dec 2025
Listing8th Dec 2025
Listing performance
Full performance ↗Issue price₹130.00
Listing price₹201.00
Current price—
Listing gain54.62%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹75.00
GMP / upper price57.69%
Est. listing₹205.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens1st Dec 2025
Closes3rd Dec 2025
Allotment4th Dec 2025
Refund5th Dec 2025
Demat5th Dec 2025
Listing8th Dec 2025
Subscription demand
Full bidding ↗QIB155.91×
sHNI505.50×
bHNI571.53×
NII / HNI571.53×
Retail463.13×
Total437.60×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Max) | 2 | 2000 | ₹260,000 |
| S-HNI (Min) | 3 | 3000 | ₹390,000 |
| S-HNI (Max) | 7 | 7000 | ₹910,000 |
| B-HNI (Min) | 8 | 8000 | ₹1,040,000 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand | ₹11.50 Cr |
| Setting up a new manufacturing facility located at Mauje-Peth in Amravati (Proposed facility) | ₹7.84 Cr |
| General Corporate Purposes | ₹2.13 Cr |
| Issue Expenses | ₹2.66 Cr |
| Total | ₹24.14 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue14.44₹ Cr · -42.9% vs prior year
EBITDA4.33₹ Cr · -36.5% vs prior year
PAT3.20₹ Cr · -39.2% vs prior year
Assets15.68₹ Cr · +34.8% vs prior year
Net Worth13.55₹ Cr · +30.9% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2024
Assets8.03
Total Income22.28
EBITDA6.64
Profit After Tax5.02
NET Worth5.10
Reserves and Surplus5.09
Total Borrowing0.04
31 Mar 2025
Assets11.63
Total Income25.30
EBITDA6.82
Profit After Tax5.26
NET Worth10.35
Reserves and Surplus5.35
30 Sep 2025
Assets15.68
Total Income14.44
EBITDA4.33
Profit After Tax3.20
NET Worth13.55
Reserves and Surplus8.54
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 68.04% |
| ROCE | 68.32% |
| RoNW | 50.77% |
| PAT Margin | 21.01% |
| EBITDA Margin | 27.30% |
| Price to Book Value | 6.29 |
Valuation & shareholding
Pre-IPO EPS10.50
Post-IPO EPS9.32
Pre-IPO P/E12.38
Post-IPO P/E13.95
Promoter holding pre99.96%
Promoter holding post72.95%
Market cap₹89.17 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Ravelcare IPO | — | 13.95 x | — | — |
| H. R. IPO | — | 17.53 x | — | — |
| Anondita Medicare IPO | — | 15.98 x | — | — |
| Medistep Healthcare IPO | — | 14.74 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Marketing and advertisement expenses toward enhancing the awareness and visibility of the brand | ₹11.50 Cr |
| Setting up a new manufacturing facility located at Mauje-Peth in Amravati (Proposed facility) | ₹7.84 Cr |
| General Corporate Purposes | ₹2.13 Cr |
| Issue Expenses | ₹2.66 Cr |
| Total | ₹24.14 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Marwadi Chandarana Intermediaries Brokers...
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-10.
IPO UPDATE ALERTS
Register for IPO Updates →Track Ravelcare without missing an update
Register for subscription, GMP, allotment and listing notifications.